| scholarly article | Q13442814 |
| P2093 | author name string | Toba Kazemi | |
| Omid Rajabi | |||
| Gholamreza Sharifzadeh | |||
| Tayyebe Kermani | |||
| Khadije Ilkhani | |||
| Somayye Molki | |||
| P2860 | cites work | Therapeutic effects of saffron (Crocus sativus L.) in digestive disorders: a review | Q26741148 |
| Razi's Al-Hawi and saffron (Crocus sativus): a review | Q26766059 | ||
| The effects of Crocus sativus (saffron) and its constituents on nervous system: A review | Q26782800 | ||
| Evaluation of antioxidant activities of bioactive compounds and various extracts obtained from saffron (Crocus sativus L.): a review | Q26830387 | ||
| The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats | Q28254857 | ||
| Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women | Q34122747 | ||
| Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? | Q34361973 | ||
| Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. | Q34573384 | ||
| Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 | ||
| Metabolic syndrome: definitions and controversies. | Q35047747 | ||
| Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial | Q36140230 | ||
| Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high-fat diet-induced obese rats | Q36172121 | ||
| Saffron: A Natural Potent Antioxidant as a Promising Anti-Obesity Drug | Q36335092 | ||
| Comparison of components of metabolic syndrome in premature myocardial infarction in an Iranian population: a case -control study | Q36605878 | ||
| Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers | Q36799649 | ||
| Toxicology effects of saffron and its constituents: a review | Q37683739 | ||
| Anticarcinogenic effect of saffron (Crocus sativus L.) and its ingredients | Q37718603 | ||
| Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease | Q37982645 | ||
| Cardiovascular effects of saffron: an evidence-based review. | Q38052907 | ||
| Saffron: a promising natural medicine in the treatment of metabolic syndrome | Q39012853 | ||
| Extraction and purification of crocin from saffron stigmas employing a simple and efficient crystallization method | Q42727544 | ||
| Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats | Q43219311 | ||
| Study of the effect of crocin on rat experimental hyperlipemia and the underlying mechanisms | Q46418800 | ||
| Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. | Q46436022 | ||
| Crocetin attenuates atherosclerosis in hyperlipidemic rabbits through inhibition of LDL oxidation | Q46902681 | ||
| Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails | Q79364793 | ||
| Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase | Q79861789 | ||
| Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats | Q83815842 | ||
| Risk factors for premature myocardial infarction: a matched case-control study | Q84845665 | ||
| P433 | issue | 4 | |
| P921 | main subject | Crocus sativus | Q15041677 |
| metabolic syndrome | Q657193 | ||
| P304 | page(s) | 228-232 | |
| P577 | publication date | 2017-10-01 | |
| P1433 | published in | Journal of Research in Pharmacy Practice | Q26841800 |
| P1476 | title | The Efficacy of Crocin of Saffron (Crocus sativus L.) on the Components of Metabolic Syndrome: A Randomized Controlled Clinical Trial | |
| P478 | volume | 6 |
| Q94453074 | Crocin prevents metabolic syndrome in rats via enhancing PPAR-gamma and AMPK |
| Q89306506 | The Protective Role of Crocus Sativus L. (Saffron) Against Ischemia- Reperfusion Injury, Hyperlipidemia and Atherosclerosis: Nature Opposing Cardiovascular Diseases |
| Q97520367 | The effect of crocin supplementation on glycemic control, insulin resistance and active AMPK levels in patients with type 2 diabetes: a pilot study |
Search more.